We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$10.9B
AUM Growth
+$354M
Cap. Flow
-$371M
Cap. Flow %
-3.39%
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Financials 13.41%
3 Healthcare 12.54%
4 Consumer Discretionary 11.8%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLYM
2101
DELISTED
Plymouth Industrial REIT
PLYM
$183K ﹤0.01%
10,839
-965
-8% -$15.1K
ERII icon
2102
Energy Recovery
ERII
$397M
$182K ﹤0.01%
9,929
-7,210
-42% -$115K
LTRPA
2103
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$182K ﹤0.01%
+28,540
New +$154K
IDYA icon
2104
IDEAYA Biosciences
IDYA
$3.56B
$182K ﹤0.01%
+7,726
New +$149K
NTST
2105
NETSTREIT Corp
NTST
$2.08B
$182K ﹤0.01%
+9,819
New +$175K
TPC
2106
Tutor Perini Cor
TPC
$5.05B
$181K ﹤0.01%
9,574
-7,770
-45% -$132K
STTK icon
2107
Shattuck Labs
STTK
$752M
$181K ﹤0.01%
6,185
MCF
2108
DELISTED
Contango Oil & Gas Co.
MCF
$180K ﹤0.01%
+46,174
New +$177K
MPAA icon
2109
Motorcar Parts of America
MPAA
$230M
$180K ﹤0.01%
8,000
PRLD icon
2110
Prelude Therapeutics
PRLD
$456M
$180K ﹤0.01%
4,148
+29
+0.7% +$1.92K
CCRN
2111
DELISTED
Cross Country Healthcare
CCRN
$179K ﹤0.01%
14,352
+8,900
+163% +$94.4K
MASS icon
2112
908 Devices
MASS
$414M
$179K ﹤0.01%
+3,696
New +$211K
TBRG
2113
DELISTED
TruBridge
TBRG
$179K ﹤0.01%
5,856
MGI
2114
DELISTED
MoneyGram International, Inc. New
MGI
$179K ﹤0.01%
27,211
+11,231
+70% +$82.2K
PACK icon
2115
Ranpak Holdings
PACK
$464M
$179K ﹤0.01%
8,903
CRNX icon
2116
Crinetics Pharmaceuticals
CRNX
$8.96B
$178K ﹤0.01%
11,648
-1,084
-9% -$16.8K
VRS
2117
DELISTED
Verso Corporation
VRS
$177K ﹤0.01%
12,152
+6,326
+109% +$83.2K
ALNT icon
2118
Allient
ALNT
$1.94B
$177K ﹤0.01%
5,181
FDMT icon
2119
4D Molecular Therapeutics
FDMT
$621M
$177K ﹤0.01%
+4,083
New +$181K
TBCH
2120
Turtle Beach Corp
TBCH
$230M
$177K ﹤0.01%
6,636
KYMR icon
2121
Kymera Therapeutics
KYMR
$9.48B
$177K ﹤0.01%
4,549
BOC icon
2122
Boston Omaha
BOC
$436M
$177K ﹤0.01%
5,973
TECX
2123
Tectonic Therapeutic
TECX
$720M
$176K ﹤0.01%
1,154
-45
-4% -$7.32K
SRG
2124
Seritage Growth Properties
SRG
$131M
$175K ﹤0.01%
9,546
-5,454
-36% -$101K
CBB
2125
DELISTED
Cincinnati Bell Inc.
CBB
$175K ﹤0.01%
11,385
-7,585
-40% -$116K

Similar funds

MetLife Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.

  • MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
  • MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
  • MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
  • MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
  • MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
  • MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.